Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Cost of Revenue (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Cost of Revenue for 10 consecutive years, with $13.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 41.46% to $13.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $63.7 million, a 0.95% decrease, with the full-year FY2025 number at $63.7 million, down 0.95% from a year prior.
  • Cost of Revenue was $13.8 million for Q4 2025 at Orthopediatrics, down from $18.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $24.2 million in Q4 2022 to a low of -$1.2 million in Q4 2021.
  • A 5-year average of $12.9 million and a median of $13.0 million in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: skyrocketed 2071.93% in 2022, then plummeted 55.03% in 2023.
  • Orthopediatrics' Cost of Revenue stood at -$1.2 million in 2021, then surged by 2071.93% to $24.2 million in 2022, then tumbled by 55.03% to $10.9 million in 2023, then surged by 116.63% to $23.6 million in 2024, then plummeted by 41.46% to $13.8 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Cost of Revenue are $13.8 million (Q4 2025), $18.7 million (Q3 2025), and $17.1 million (Q2 2025).